President Barack Obama said Monday he is allowing federal taxpayer dollars to fund significantly broader research on embryonic stem cells because "medical miracles do not happen simply by accident," and promised his administration would make up for the ground lost under his predecessor.
Fulfilling a campaign promise, Mr. Obama signed an executive order expected to set in motion increased research that supporters believe could uncover cures for serious ailments from diabetes to paralysis.
Mr. Obama's action, before a packed East Room audience, reverses former President George W. Bush's policy on stem cell research by undoing a 2001 directive that banned federal funding for research into stem lines created after that date.
Mr. Bush limited the use of taxpayer money to only the 21 stem cell lines that had been produced before his decision. He argued he was defending human life because days-old embryos - although typically from fertility clinics and already destined for destruction - are destroyed to create the stem cell lines.
The Obama order reverses that without addressing a separate legislative ban, which precludes any federal money paying for the development of stem cell lines. The legislation, however, does not prevent funds for research on those lines created without federal funding. (Read more about what this Executive Order will do -- and won't do.)
Researchers say the newer lines created with private money during the period of the Bush ban are healthier and better suited to creating treatment for diseases. Embryonic stem cells are master cells that can morph into any cell of the body. Scientists hope to harness them so they can create replacement tissues to treat a variety of diseases - such as new insulin-producing cells for diabetics, cells that could help those with Parkinson's disease or maybe even Alzheimer's, or new nerve connections to restore movement after spinal injury.
Mr. Obama called his decision a "difficult and delicate balance," an understatement of the intense emotions generated on both sides of the long, contentious debate. He said he came down on the side of the "majority of Americans" who support increased federal funding for the research, both because strict oversight would prevent problems and because of the great and lifesaving potential it holds.
CBS News polling on the topic shows that Americans do support medical research using embryonic stem cells. In 2007, the last time CBS News asked the question, sixty-five percent said they approved compared to twenty-five percent who disapproved. The number of those who approved had gone up steadily since the 2004 when fifty percent approved. (Read more about the polling.)
"Rather than furthering discovery, our government has forced what I believe is a false choice between sound science and moral values," Mr. Obama said. "In this case, I believe the two are not inconsistent. As a person of faith, I believe we are called to care for each other and work to ease human suffering. I believe we have been given the capacity and will to pursue this research and the humanity and conscience to do so responsibly." (Read all of Mr. Obama's remarks.)
Mr. Obama warned against overstating the eventual benefits of the research. But he said his administration "will vigorously support scientists who pursue this research," taking a slap at his predecessor in the process.
"I cannot guarantee that we will find the treatments and cures we seek. No president can promise that. But I can promise that we will seek them actively, responsibly, and with the urgency required to make up for lost ground."
It's a matter of competitive advantage globally as well, the president argued.
"When government fails to make these investments, opportunities are missed. Promising avenues go unexplored. Some of our best scientists leave for other countries that will sponsor their work. And those countries may surge ahead of ours in the advances that transform our lives," Mr. Obama said.
Early Show medical contributor Dr. Holly Phillips pointed out that such research was never banned or illegal. "The question that we're addressing today is what role, if any, federal funding should have" in this research.
"Many scientists for the last eight years have been complaining that they're spending more time trying to find funding for their research than actually doing their research. So for them this will really have a profound effect," Phillips said. "Certainly on an international level in medicine we're so excited about this research and the potential for healing that it has. So I think less red tape will have a profound effect."
Of the diseases or conditions that may be most affected by the end of the federal ban, Phillips said, "People are most excited about the neurological illnesses, things like Parkinson's and Alzheimer's. A group in California will start using embryonic stem cells in humans to hopefully cure spinal cell injuries for people who have been paralyzed from the waist down. We're also seeing some hope in treating diabetes, heart disease and even strokes. So really, millions of people could be affected by this research."
"We've got eight years of science to make up for," said Dr. Curt Civin, whose research allowed scientists to isolate stem cells and who now serves as the founding director of the University of Maryland School of Medicine's Center for Stem Cell Biology and Regenerative Medicine. "Now the silly restrictions are lifted."
Mr. Bush and his supporters said they were defending human life; days-old embryos - typically from fertility-clinic leftovers otherwise destined to be thrown away - are destroyed for the stem cells.
Family Research Council, which advocates for a "Judeo-Christian worldview" and warns against the reproductive cloning of a human being, opposes the use of embryonic stem cells, promoting instead adult stem cells as being superior.
Of Mr. Obama's new order, FRC's Dr. David Prentice told CBS' The Early Show, "In terms of scientific advances I don't think we are going to see anything for this. This is more of an ideological move."
House Republican Leader John Boehner said the president's repeal of the ban, "runs counter to President Obama's promise to be a president for all Americans. For a third time in his young presidency, the president has rolled back important protections for innocent life, further dividing our nation at a time when we need greater unity to tackle the challenges before us." (Read more about Republican reaction to the move.)
The president was insistent that his order would not open the door to human cloning.
"We will develop strict guidelines, which we will rigorously enforce, because we cannot ever tolerate misuse or abuse," Mr. Obama said. "And we will ensure that our government never opens the door to the use of cloning for human reproduction. It is dangerous, profoundly wrong, and has no place in our society, or any society."
Mr. Obama also issued a memo promising to restore "scientific integrity to government decision-making." That policy change was aimed more broadly than the stem cell debate, to reach into areas such as climate change as well.
"Promoting science isn't just about providing resources it is also about protecting free and open inquiry," Mr. Obama said. "It is about letting scientists like those here today do their jobs, free from manipulation or coercion, and listening to what they tell us, even when it's inconvenient especially when it's inconvenient. It is about ensuring that scientific data is never distorted or concealed to serve a political agenda and that we make scientific decisions based on facts, not ideology.
Mr. Obama said the presidential memorandum was the beginning of a process that would ensure that his administration: bases its decision "on the soundest science," appoints scientific advisers based on their credentials and experience, not their politics or ideology, and is "open and honest" about the science behind its decisions.
"We view what happened with stem cell research in the last administration is one manifestation of failure to think carefully about how federal support of science and the use of scientific advice occurs," said Harold Varmus, chairman of the White House's Council of Advisers on Science and Technology.
2009 CBS Interactive Inc. All Rights Reserved. This material may not be published, broadcast, rewritten, or redistributed. The Associated Press contributed to this report.
Original post:
Obama Ends Stem Cell Research Ban - CBS News
- The global gene therapy market is valued at an estimated USD 7.3 billion in 2022 and is projected to reach USD 17.2 billion by 2027, at a CAGR of... - August 3rd, 2022
- T-cell Lymphoma Market worth $2.89 billion by 2030 - Exclusive Report by InsightAce Analytic - PR Newswire UK - July 17th, 2022
- Cataract Treatment Market Trends, Drivers and Growth Projection Up to 2029 Alcon Vision LLC, Essilor, Ziemer Ophthalmic Systems, Bausch Health,... - July 17th, 2022
- Global Hunter Syndrome Treatment Market Analysis to 2026 - Focus on Hematopoietic Stem Cell Transplant (HSCT) and Enzyme Replacement Therapy (ERT) -... - July 17th, 2022
- Religious Groups Official Positions on Stem Cell Research ... - December 8th, 2021
- Regenerative Stem Cells Knee Pain Treatment London, UK ... - December 8th, 2021
- The Case Against Embryonic Stem Cell Research: An ... - December 8th, 2021
- The mTOR Pathway in Pluripotent Stem Cells: Lessons for ... - December 8th, 2021
- Hematopoietic Stem Cell Differentiation Pathways & Lineage ... - December 8th, 2021
- Dutch stem cell biotech Neuroplast secures 10 million ... - December 8th, 2021
- Stem Cell Banking Market Size 2021, Latest Business Opportunities, Growth Statistics, Industry Share, Upcoming Trends, Covid-19 Impact, Demand... - December 8th, 2021
- Removal of sanctions major reason for Iran's signature on JCPOA - Tehran Times - December 8th, 2021
- Primary Cells Market Research Report by Origin, by Cell Type, by End-user, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19 - Yahoo... - August 4th, 2021
- Global Stem Cell Assay Market growth will help industry players with different potential opportunities to explore the market 2021-2027 The Manomet... - August 4th, 2021
- US trade and investment in Africa - Brookings Institution - August 4th, 2021
- Stem Cell Banking Market Analysis Revealing Key Drivers & Growth Trends through 2029: CCBC, CBR, ViaCord, Esperite, Vcanbio, and others. KSU |... - February 14th, 2021
- Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size Is Expected To Generate Huge Profits and Competitive Outlook - The Courier - February 14th, 2021
- Coronavirus Briefing: What Happened Today - The New York Times - February 6th, 2021
- Global Placental Stem Cells (PSCS) Market 2020: Opportunity and Growth Analysis||LifeCell International Pvt. Ltd., StemCyte India Therapeutics Pvt.... - February 6th, 2021
- India Cord Stem Cell Banking Market Witness an Outstanding Growth and Strong Revenue and Forecast to 2026 KSU | The Sentinel Newspaper - KSU | The... - January 23rd, 2021
- Global Placental Stem Cells (PSCS) Market Is Expected To Gain Market Growth In The Forecast Period Of 2020 To 2027||ESPERITE NV, LifeCell... - January 23rd, 2021
- Massive Growth Of Bone Marrow Market Size Strong Revenue and Competitive Outlook KSU | The Sentinel Newspaper - KSU | The Sentinel Newspaper - January 23rd, 2021
- Stem Cell Characterization Kits Market Trends, Forecast, and Analysis by 2018 to 2026 NeighborWebSJ - NeighborWebSJ - January 23rd, 2021
- Stem Cell Therapy Market 2021-2026 Insights on Type, Region and Comprehensive Analysis of the Development Factors in the Industry Reviewindependent -... - January 23rd, 2021
- Doctor: COVID-19 cases will continue to slowly go down, but were not out of the woods - Yahoo Money - January 23rd, 2021
- Global Blood and Organ Bank Market 2021 Overview, Trends, Growth Factors and Leading Players With Detailed Analysis of Industry Structure The Courier... - January 23rd, 2021
- Global Myelodysplastic syndromes (MDS) Market With COVID 19 Impact Analysis| Leading Players In-depth Analysis Research Report Foresight to 2027 KSU... - January 23rd, 2021
- The 11 most mind-blowing, awe-inspiring health discoveries and innovations of 2020 - Business Insider - Business Insider - December 22nd, 2020
- Cultured Protein: A Guide To Every Cell-Based Meat Startup In The World Right Now - Green Queen Media - December 22nd, 2020
- Comprehensive Report on Animal Stem Cell Therapy Market 2021 | Size, Growth, Demand, Opportunities & Forecast To 2027 | ANIMAL CELL THERAPIES,... - December 22nd, 2020
- Comprehensive Report on Cancer Stem Cell Market 2020 | Size, Growth, Demand, Opportunities & Forecast To 2026 | Thermo Fisher Scientific, Inc.,... - December 22nd, 2020
- Report On Smart Sensor Market to 2026: (Industry Insights, Company Overview and Investment Analysis) - Farming Sector - December 22nd, 2020
- Latest Study Explores The IVF Market Update 3 Reasons 2021 Could Be The Year Of Great Turnaround - Farming Sector - December 22nd, 2020
- Global Primary Antibodies Market To Reflect Impressive Growth Rate by 2028||Leading Players-Thermo F - PharmiWeb.com - December 22nd, 2020
- Rapper Trae Tha Truth gives back to homeless after Thanksgiving - Yahoo News - December 22nd, 2020
- Haywards Heath woman's bid to fund stem cell treatment to combat MS - Mid Sussex Times - December 14th, 2020
- Regenerative Medicine: Market Trends and Legal Developments on the Horizon for 2021 - MedTech Intelligence - December 14th, 2020
- Worldwide Stem Cell Therapy Market Insights to 2025 - Analysis and Forecasts - GlobeNewswire - December 4th, 2020
- Impact Of Covid-19 on Stem Cell Assay Market 2020 Industry Challenges, Business Overview and Forecast Research Study 2026 - The Market Feed - December 4th, 2020
- Stem Cells Market is Expected to Thrive at Impressive CAGR by 2025 - The Haitian-Caribbean News Network - December 4th, 2020
- Nobel Prize history from the year you were born - Albany Democrat Herald - December 4th, 2020
- Stem Cell Therapy Market Size, Share, Global Market Research and Industry Forecast Report, 2025 (Includes Business Impact Of Covid-19) - The... - December 4th, 2020
- Stem Cell Assay Market Report 2020 Potential Effect on Upcoming Future Growth by Top Vendors: GE Healthcare, Promega Corporation, Thermo Fisher... - December 4th, 2020
- Transfection Technologies Market Size 2020 | Global Business Strategies, Growing CAGR of 20.0%, Industry Revenue, Opportunities-Aldrich Co Thermo... - December 4th, 2020
- Membrane Filtration Devices Market with COVID-19 Impact, Size 2020, Share, Industry Trends, Future Growth, Regional Overview, Revenue and Forecast... - December 4th, 2020
- Whole Genome Bisulfite Sequencing (WGBS) Market Market To Grow At A CAGR Of 12.90% In The Forecast Period Of 2020 To 2027 | Major Giants Illumina,... - December 4th, 2020
- Global Stem Cell Banking Market to Get Expansion admist COVID 19, Scope With Advanced Technologies Top Key Players and Forecast 2020-2027 - The... - November 28th, 2020
- Scaffold Technology Market Research Report by Product, by Application, by End-User - Global Forecast to 2025 - Cumulative Impact of COVID-19 -... - November 28th, 2020
- Global Cell Therapy Technologies Market 2020 by Manufacturers, Countries, Type and Application, Forecast to 2026 - Cheshire Media - November 28th, 2020
- Global Animal Cell Culture Market Professional Survey 2019 by Manufacturers, Regions, Types and Applications, Forecast to 2027 by Reportspedia -... - November 28th, 2020
- Global Seed Treatment Fungicides Market 2020 Size Share Upcoming Trends Segmentation And Forecast To 2025 - The Courier - November 28th, 2020
- Stem Cell Source Market Technology Advancements and Business Outlook 2020-2026 - PharmiWeb.com - November 19th, 2020
- Comprehensive Report on Stem Cell Assay Market 2020 | Size, Growth, Demand, Opportunities & Forecast To 2026 | Bio-Techne Corporation, Promega... - November 19th, 2020
- Cell Therapy Market 2020-2025 Business Strategies JCR Pharmaceuticals Co., Ltd., Kolon TissueGene, Inc.; and Medipost - The Think Curiouser - November 19th, 2020
- Impact Analysis of Covid-19 On Global Stem Cell Assay Market Continues to Expand to Support Development and Top Players: Merck & Co., Thermo... - November 19th, 2020
- Global Cell Expansion Market Size 2020 | Growth Opportunities, Top Leaders, Revenue, Regional Overview and Forecast to 2027 - PRnews Leader - November 19th, 2020
- Primary Cells Market Research Report by Origin, by Cell Type, by End-user - Global Forecast to 2025 - Cumulative Impact of COVID-19 - GlobeNewswire - November 19th, 2020
- Global Cell and Gene Therapy Market 2020 Key Drivers and Challenges, Opportunities and Forecast Insights by 2025 - KYT24 - November 19th, 2020
- Asset Tracking and Inventory Management Solutions Market outlook by industry size share revenue regions and top key players analysis - The Think... - November 19th, 2020
- DAPT Market to Witness Increase in Revenues by 2020-2028 - The Think Curiouser - November 19th, 2020
- Stem Cell Umbilical Cord Blood Market to Enable the Stakeholders to Capitalize on the Prevailing Industry Opportunities with Investment Analysis By... - October 31st, 2020
- Impact Of Covid 19 On Adult Stem Cells Market 2020 Industry Challenges, Business Overview And Forecast Research Study 2026 - PRnews Leader - October 31st, 2020
- Global Stem Cell Media Market Dynamics Analysis, Production, Supply and Demand, Covered in the Latest Research 2020-2025 - re:Jerusalem - October 31st, 2020
- Comprehensive Report on NK Cell Therapy and Stem Cell Therapy Market 2020 | Size, Growth, Demand, Opportunities & Forecast To 2026 | Chipscreen... - October 31st, 2020
- Mesenchymal Stem Cells Market Augmented Expansion to Be Registered by 2020-2025 - Eurowire - October 31st, 2020
- Global Induced Pluripotent Stem Cells (iPSCs) Market 2020 with COVID-19 After Effects Growth Drivers, Top Key Players, Industry Segments and Forecast... - October 31st, 2020
- Canine Stem Cell Therapy Market Overview, Development by Companies and Comparative Analysis by 2026 - The Think Curiouser - October 31st, 2020
- Global Adipose Derived Stem Cell Therapy Market 2020 Leading Players, Industry Updates, Comprehensive Analysis and Forecast 2025 - re:Jerusalem - October 31st, 2020
- Outlook on the Regenerative Medicine Global Market to 2025 - Impact of COVID-19 on the Market - GlobeNewswire - October 31st, 2020
- Rising Adoption of Cell Therapy Processing Market by 2020-2027 with Major Giants: BioTime, Inc., Regeneus Ltd., Targazyme, Inc., Bone Therapeutics,... - October 31st, 2020
- Cancer Stem Cells (CSCs) Market to Flourish with an Impressive Cagr During 2020-2027 - The Think Curiouser - October 31st, 2020
- Stem Cell Cryopreservation Equipment Market : In-depth Analysis to Understand the Competitive Outlook of the Global Industry with Future Estimations -... - October 31st, 2020
- Biologics Safety Testing Market : Segmentation, Industry Trends and Development to 2026 - Eurowire - October 31st, 2020
- How Humanity Spent Its First 20 Years in Orbit Aboard the ISS - WIRED - October 31st, 2020
- What to Know in Washington: Provisional Ballots May Play Role - Bloomberg Government - October 31st, 2020
- Impact of COVID-19 on Animal Cell Culture Market 2020 | Size, Growth, Demand, Opportunities & Forecast To 2026 | Life Technologies, Thermo Fisher,... - October 31st, 2020
- Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Research Study 2020 Insights with COVID-19 Impact Analysis by 2020Orange... - August 30th, 2020
- Global Cell Isolation Technology Market 2020 Analysis, Types, Applications, Forecast and COVID-19 Impact Analysis 2025 - Scientect - August 30th, 2020
- Suramin Sodium Market Projected to Witness a Single-Digit CAGR During 2019-2025 - StartupNG - August 30th, 2020
- Stem Cell Characterization and Analysis Tool Market Growth, Size, Opportunities and Analysis Forecast 2020 - 3rd Watch News - July 12th, 2020